SUN PHARMACEUTICALS - Sun shines at home and abroad
Sun Pharmaceuticals may not be as renowned as some of its Indian peers, but it is capitalising on the country's low-cost environment as well as growing fast overseas. While patent changes may become an issue, the firm's future certainly seems bright. Chris Wright sheds light on a home-grown success story.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts